Cargando…
Nonglycemic Outcomes of Antidiabetic Medications
IN BRIEF The number of medications used to treat diabetes has increased dramatically in the past 15 years. With so many options that have shown significant A1C improvement, it is important to consider side effects, precautions, and additional benefits these agents may offer. This article is a review...
Autores principales: | Morse, Christopher, Sze, David, Patel, Dhiren, Goldman, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468830/ https://www.ncbi.nlm.nih.gov/pubmed/31057219 http://dx.doi.org/10.2337/cd18-0015 |
Ejemplares similares
-
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014) -
Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes
por: Trujillo, Jennifer M., et al.
Publicado: (2017) -
GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
por: Ryan, Donna, et al.
Publicado: (2015) -
Glycemic and nonglycemic mechanisms of congenital malformations in hyperglycemic pregnancies: a narrative review
por: Negrato, Carlos Antonio, et al.
Publicado: (2022) -
Multiple Nonglycemic Genomic Loci Are Newly Associated With Blood Level of Glycated Hemoglobin in East Asians
por: Chen, Peng, et al.
Publicado: (2014)